Original language | English |
---|---|
Pages (from-to) | 1129-1131 |
Number of pages | 3 |
Journal | Journal of Allergy and Clinical Immunology |
Volume | 136 |
Issue number | 4 |
DOIs | |
State | Published - Oct 2015 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Does azithromycin modify viral load during severe respiratory syncytial virus bronchiolitis? / Beigelman, Avraham; Bacharier, Leonard B.; Baty, Jack; Buller, Richard; Mason, Sheila; Schechtman, Kenneth B.; Sajol, Geneline; Isaacson-Schmid, Megan; Castro, Mario; Storch, Gregory A.
In: Journal of Allergy and Clinical Immunology, Vol. 136, No. 4, 10.2015, p. 1129-1131.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Does azithromycin modify viral load during severe respiratory syncytial virus bronchiolitis?
AU - Beigelman, Avraham
AU - Bacharier, Leonard B.
AU - Baty, Jack
AU - Buller, Richard
AU - Mason, Sheila
AU - Schechtman, Kenneth B.
AU - Sajol, Geneline
AU - Isaacson-Schmid, Megan
AU - Castro, Mario
AU - Storch, Gregory A.
N1 - Funding Information: This study was supported by the Washington University Institute of Clinical and Translational Sciences (grant no. UL1 TR000448 from the National Center for Advancing Translational Sciences , subaward KL2 TR000450) and the Children's Discovery Institute of Washington University and St Louis Children's Hospital . This study was supported in part (REDCap database) by the National Institutes of Health's Clinical and Translational Science Award (CTSA) (grant no. UL1 TR000448 ) and the Siteman Comprehensive Cancer Center and the National Cancer Institute (NCI) Cancer Center (support grant no. P30 CA091842 ). Funding Information: Disclosure of potential conflict of interest: L. B. Bacharier has received research support from the National Institutes of Health (NIH) and from National Heart, Lung, and Blood Institute/NIH AsthmaNet and has received consultancy fees from Aerocrine, AstraZeneca, Genentech/Novartis, GlaxoSmithKline, Merck, Schering, and Teva. M. Castro has received grants from the NIH during the conduct of the study; personal fees from Asthmatx/Boston Scientific, IPS/Holaria, Genentech, Merck, GSK, Genentech, Boehringer-Ingelheim, and Elsevier; grants from Boston Scientific, Amgen, Ception/Cephalon/Teva, Genetech, Medimmune, Merck, Novartis, GSK, Sanofi-Aventis, Vectura, NextBio, and KalaBios; and stock options from Sparo, Inc, all outside the submitted work. The rest of the authors have received research support from the NIH.
PY - 2015/10
Y1 - 2015/10
UR - http://www.scopus.com/inward/record.url?scp=84943456304&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2015.06.011
DO - 10.1016/j.jaci.2015.06.011
M3 - Article
C2 - 26215052
AN - SCOPUS:84943456304
VL - 136
SP - 1129
EP - 1131
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
SN - 0091-6749
IS - 4
ER -